For healthcare organizations to improve care delivery without relying solely on electronic health records, chief information officers (CIOs) should consider standalone platforms that can be used in conjunction with EHRs while maintaining a focus on accurate patient data and simplified clinical workflows, according to a recent report.

Over the past few years, the use of telehealth and remote patient monitoring has grown in popularity throughout the United States, with a recent survey revealing that 36% of US consumers use telehealth to replace in-person visits to their physician.

This has created an opportunity for health systems to digitally transform their care delivery model; however, not all health systems have the resources, such as patient monitors, or the organizational support necessary to make this transformation a success.

Among the clinical community, there is a general lack of confidence in the accuracy and reliability of data, particularly when it comes to patient reporting and self-monitoring. This is especially true when it comes to patient reporting. Today, despite the obvious advantages of using connected devices to manage large chronic populations, the situation remains unchanged despite the obvious advantages of doing so.

The chief information officers (CIOs) of healthcare organizations are increasingly looking beyond electronic health records to standalone platforms to improve the quality of care they provide to patients. It is also part of their job responsibilities for CIOs to make strategic use of the tools that are available to them and work toward a unified vision for the organization's transformation in order to achieve success in their respective organizations.

To ensure that these providers make the best use of available resources while also planning for the future, CIOs must take into account the following considerations:

It is essential to have a dependable patient data collection system in place, as well as the ability to obtain reimbursement for services rendered.

However, despite the fact that the market is flooded with new health devices and wearables right now, not all of them have been approved for reimbursement by the Centers for Medicare and Medicaid Services (CMS). In order to be eligible for CMS reimbursement, a device must first be approved by the Food and Drug Administration (FDA) and thus be considered eligible for reimbursement by the federal government.

The Food and Drug Administration categorizes a patient monitor's assessment of the risk to human life posed by a clinically significant risk to human life into three categories based on the level of risk to human life that the patient monitor believes they pose to the patient monitor price. This can be seen, for example, when a medical device is subjected to a number of regulatory processes, one of which may be participation in a clinical study.

Clinicians can keep track of their patients' vital signs from a distance with the help of remote etco2 patient monitor devices, allowing them to make informed decisions in real time and save valuable time for their patients. The use of remote patient monitoring devices is becoming more and more popular. It is possible for clinicians to monitor patients' vital signs with this type of device, including their respiratory and heart rates, as well as their temperature, heart rate variability, and blood oxygen saturation levels, among other things.